.jpg?format=webp&quality=80&width=3840)
The study evaluated the detection rate of prostate cancer in men who underwent transperineal ultrasound-guided prostate biopsy using MRI cognitive fusion. The overall detection rate of prostate cancer in biopsy-naive patients was 73%, with a 63% detection rate of clinically significant prostate cancer. The study found a low incidence of procedure-related complications and a low hospitalization rate compared to other biopsy methods. The researchers concluded that transperineal prostate biopsy with MRI cognitive fusion is easy to perform in an outpatient setting and has a high detection rate of clinically significant prostate cancer with low procedure-related complications.
Like
Save
Share